Non-invasive Positive Pressure Ventilation (NIPPV) in the Home for the Treatment of Chronic Respiratory Failure Consequent to COPD Effective Date 6/9/2025
Implementation Date 10/22/2025
Initial Coverage Criteria RAD with Backup Rate
Covered for chronic respiratory failure due to COPD when all the following are met: ABG showing PaCO2 ≥ 52 mmHg during awake hours while breathing their prescribed FiO2; AND Sleep apnea is not the predominant cause of hypercapnia (no sleep test required); AND The patient demonstrates ONE of the following characteristics: •
Stable COPD, without increase in or new onset of more than one respiratory symptom lasting two or more days and no change of pharmacological treatment during the two-week period before initiation of NIV, OR
•
Hypercapnia present for at least two weeks post hospitalization after resolution of an exacerbation of COPD requiring acute NIV.
By the end of the initial six-month period, a RAD with backup rate feature must be utilized as high intensity therapy, defined as a minimum IPAP ≥15 cm H2O, and backup respiratory rate of at least 14 breaths per minute.
RAD without Backup Rate Coverage for a RAD without backup rate for a patient with CRF consequent to COPD who cannot tolerate high intensity NIV or for whom the backup rate feature is otherwise medically inappropriate. A RAD without backup rate feature is covered in the home for an initial six-month period for patients with COPD when all of the following criteria are met: ABG showing PaCO2 ≥ 52 mmHg while breathing their prescribed FiO2, AND Sleep apnea is not the predominant cause of the hypercapnia (no sleep testing required)
RAD Upon Hospital Discharge Coverage for a RAD in the home with or without backup rate feature immediately upon hospital discharge for an initial six-month period for patients with acute or chronic respiratory failure due to COPD if BOTH of the following are met: If the patient required either a RAD or ventilator within the 24-hour period prior to hospital discharge, AND the treating clinician determines that the patient is at risk of rapid symptom exacerbation or rise in PaCO2 after discharge.
Continued Need Requires Two Evaluations in the First Year •
By 6 months: » Usage ≥ 4 hrs/day, 70%+ of days in 30 days. » Clinical improvement must be shown: • PaCO₂ normalized, stabilized, or reduced by 20%, or • Improved symptoms (headache, fatigue, SOB, confusion, sleep).
•
Between months 7–12: » Same usage standard.
•
Ongoing when patient owned for supplies » Must meet the 4 hrs/day, 70%+ usage for continued supply coverage.